Literature DB >> 26032686

Defective roles of ATP7B missense mutations in cellular copper tolerance and copper excretion.

Min Zhu1, Yi Dong2, Wang Ni3, Zhi-Ying Wu4.   

Abstract

Wilson's disease (WD) is a hereditary disorder of copper metabolism resulting from mutations within ATP7B. Clinical investigations showed that ATP7B missense mutations cause a wide variety of symptoms in WD patients, which implies that those mutations might affect ATP7B function in a number of ways and each would have deleterious consequences on normal copper distribution and lead to WD. Nonetheless, it is still unknown about the influences of those mutations on ATP7B function of increasing copper excretion and enhancing cellular copper tolerance. Here we established the stable expression cell lines of wild-type (WT) ATP7B and its four missense mutants (R778L, R919G, T935M and P992L), tested cellular copper tolerance and copper excretion using those cell lines, and also observed cellular distribution of WT ATP7B proteins and those mutants in transiently transfected cells. We found that extrinsic expressing WT ATP7B reduced CuCl2-induced copper accumulation and enhanced cellular copper tolerance by accelerating copper excretion, which was selectively compromised by R778L and P992L mutations. Further investigation showed that R778L mutation disrupted the subcellular localization and trafficking of ATP7B proteins, whereas P992L mutation only affected the trafficking of ATP7B. This indicates that ATP7B missense mutants have distinct effects on cellular copper tolerance.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP7B; Cellular copper tolerance; Copper excretion; Missense mutation; Wilson's disease

Mesh:

Substances:

Year:  2015        PMID: 26032686     DOI: 10.1016/j.mcn.2015.05.005

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  3 in total

Review 1.  Wilson's Disease in China.

Authors:  Juan-Juan Xie; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2017-03-06       Impact factor: 5.203

2.  CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.

Authors:  Rui Wei; Jiayin Yang; Chi-Wa Cheng; Wai-In Ho; Na Li; Yang Hu; Xueyu Hong; Jian Fu; Bo Yang; Yuqing Liu; Lixiang Jiang; Wing-Hon Lai; Ka-Wing Au; Wai-Ling Tsang; Yiu-Lam Tse; Kwong-Man Ng; Miguel A Esteban; Hung-Fat Tse
Journal:  JHEP Rep       Date:  2021-10-30

3.  Functional Characterization of Novel ATP7B Variants for Diagnosis of Wilson Disease.

Authors:  Sarah Guttmann; Friedrich Bernick; Magdalena Naorniakowska; Ulf Michgehl; Sara Reinartz Groba; Piotr Socha; Andree Zibert; Hartmut H Schmidt
Journal:  Front Pediatr       Date:  2018-04-30       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.